Cargando…
Amoxicillin 3 vs 5 days for chest-indrawing pneumonia in Malawian children
BACKGROUND: Evidence supporting duration of antibiotic treatment for children in low-resource African settings with chest-indrawing pneumonia is lacking. METHODS: We conducted a double-blind, randomized controlled 2-arm, non-inferiority trial in Lilongwe, Malawi with follow-up for 14 days to determi...
Autores principales: | Ginsburg, Amy Sarah, Mvalo, Tisungane, Nkwopara, Evangelyn, McCollum, Eric D., Phiri, Melda, Schmicker, Robert, Hwang, Jun, Ndamala, Chifundo B., Phiri, Ajib, Lufesi, Norman, Izadnegahdar, Rasa, May, Susanne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Massachusetts Medical Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7233470/ https://www.ncbi.nlm.nih.gov/pubmed/32609979 http://dx.doi.org/10.1056/NEJMoa1912400 |
Ejemplares similares
-
Placebo vs Amoxicillin for Nonsevere Fast-Breathing Pneumonia in Malawian Children Aged 2 to 59 Months: A Double-blind, Randomized Clinical Noninferiority Trial
por: Ginsburg, Amy Sarah, et al.
Publicado: (2018) -
Methods for conducting a double-blind randomized controlled clinical trial of three days versus five days of amoxicillin dispersible tablets for chest indrawing childhood pneumonia among children two to 59 months of age in Lilongwe, Malawi: a study protocol
por: Ginsburg, Amy Sarah, et al.
Publicado: (2018) -
Malawian children with fast-breathing pneumonia with and without comorbidities
por: Ginsburg, Amy Sarah, et al.
Publicado: (2021) -
Analysis of serious adverse events in a paediatric fast breathing pneumonia clinical trial in Malawi
por: Nkwopara, Evangelyn, et al.
Publicado: (2019) -
Malawian children with chest-indrawing pneumonia with and without comorbidities or danger signs
por: Ginsburg, Amy Sarah, et al.
Publicado: (2021)